Patanjali claims to launch Covid-19 drug for clinical trial. || Patanjali Drug for Coronavirus.

Patanjali Group, a consumer products and ayurvedic remedies company, has claimed that it is launching the COVID-19 drug for clinical trials. 

Patanjali's drug clinical trial has started in Indore and Jaipur. 

⇛These launches were made after the approval of the regulator. The company's MD Balakrishna said that the clinical trial has started in Indore and Jaipur. Patanjali got its approval last week. Companies like JSK, Johnson & Johnson, Pfizer are still running to find a successful vaccine.

⇛In March, Patanjali tried this drug on thousands of people. Patanjali has three laboratories. One of these labs is designed for COVID-19. According to Balakrishna, the Patanjali group was preparing the COVID-19 vaccine from February 2020.